Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
China's Fosun Pharma eyes spin-off Hong Kong IPO of vaccine unit
The board of Shanghai Fosun Pharmaceutical approved the spin-off and Hong Kong listing of its vaccine unit, aiming to bolster the business as biotechnology shares continue to outperform in the city's stock market. The board cleared the proposed…
Vertex Pharma upgraded at RBC Capital Markets (VRTX:NASDAQ)
RBC Capital Markets on Thursday upgraded Vertex Pharmaceuticals (VRTX) to Outperform from Sector Perform, arguing that the Boston, Massachusetts-based biotech is poised to record upside in 2026 on the back of a cystic fibrosis franchise that…
Europe's US Reality Check, Trump Sues Dimon For $5B, Big Pharma's Llama Secret
Bloomberg Daybreak EU Podcast • Browse all episodes Your morning briefing, the business news you need in just 15 minutes. On today's podcast: (1) Europe is ready to get back to work with the US, wary, frustrated and knowing it can't trust an…
Hudson pharma acquired by global investment firm
Proveris Scientific, a Hudson-based pharmaceutical product development firm, has been acquired by a subsidiary of Investindustrial, an international investment group with a U.S. office in New York City. Founded in 1995, Proveris provides testing…
Sun Pharma gets DCGI nod to make, market generic semaglutide injection in India for weight management
Sun Pharmaceutical Industries Ltd said it has received approval from the Drugs Controller General of India (DCGI) to manufacture and market a generic version of semaglutide injection. Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist…
Sun Pharma gets regulatory approval for generic semaglutide in India
Sun Pharmaceutical has received approval from the Drugs Controller General of India (DCGI) to manufacture and market a generic version of semaglutide injection, the company said, as it joins domestic drugmakers lining up to launch in India and…
Zealand Pharma A/S (OTCMKTS:ZLDPF) Shares Gap Up - Here's Why
Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report)'s share price gapped up before the market opened on Thursday. The stock had previously closed at $63.00, but opened at $67.90. Zealand Pharma A/S shares last traded at $67.90, with a volume of…
Pharmalittle: We're reading about Europe's pharma supply chain, stopping GLP-1 drugs, and more
Good morning, everyone, and welcome to the middle of the holiday-shortened week on this side of the pond. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives. So keep plugging away. After…
Ascendis Pharma A/S (NASDAQ:ASND) Hits New 12-Month High - Time to Buy?
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) reached a new 52-week high on Thursday. The company traded as high as $236.25 and last traded at $226.78, with a volume of 669088 shares. The stock had previously closed at $216.66. Get Ascendis…
Emerald Mutual Fund Advisers Trust Lowers Stock Position in BridgeBio Pharma, Inc. $BBIO
Emerald Mutual Fund Advisers Trust trimmed its stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 36.3% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 411,427 shares of the company's stock…
US Futures, Global Markets Rally After Trump Greenland Pivot
US equity futures and global stocks are sharply higher as the S&P again marches toward a new ATH while the latest vol spike subsides, after Trump's tariff pivot eased geopolitical fears, though Greenland and other flashpoints mean the optimistic…
What obesity drugmakers see next in the market: More pills, easier access and drug combinations
Top executives from drugmakers big and small told CNBC that the next phase of the obesity drug market will be defined by a broader range of treatment options and improved access for patients. CNBC spoke to executives from Eli Lilly, Novo Nordisk…
Vanguards of Health Care: Sofinnova Partners Betting on Data
“Despite all the noise — tariffs, regulation, geopolitics — the fundamentals are amazing, because our companies save people's lives and the demand for innovation is absolutely real.” says Antoine Papiernik, Sofinnova…
EWL: February Could Be Quite Big For Swiss Macro (NYSEARCA:EWL)
The iShares MSCI Switzerland ETF is heavily weighted toward healthcare and financials, with some exposure to tariff negotiations, which may be more than halved. Novartis faces considerable direct tariff risk but expects mitigation by mid-2026 as…
On This Day: Rock and Roll Hall of Fame inducts first class
The Rock and Roll Hall of Fame and Museum is seen in Cleveland on October 17, 2006. File Photo by Kevin Dietsch/UPI Pedestrians wear protective respiratory masks in Beijing on January 23, 2020, the same day the government issued lockdown orders for…
Receive a Daily briefing on Pharma Industry News
Get Started